RhumbLine Advisers’s Pulmonx LUNG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $144K | Sell |
55,661
-297
| -0.5% | -$769 | ﹤0.01% | 3396 |
|
|
2025
Q1 | $377K | Buy |
55,958
+2,455
| +5% | +$16.5K | ﹤0.01% | 2761 |
|
|
2024
Q4 | $363K | Buy |
53,503
+2,488
| +5% | +$16.9K | ﹤0.01% | 2875 |
|
|
2024
Q3 | $423K | Sell |
51,015
-691
| -1% | -$5.73K | ﹤0.01% | 2814 |
|
|
2024
Q2 | $328K | Sell |
51,706
-936
| -2% | -$5.93K | ﹤0.01% | 2945 |
|
|
2024
Q1 | $488K | Buy |
52,642
+1,734
| +3% | +$16.1K | ﹤0.01% | 2680 |
|
|
2023
Q4 | $649K | Buy |
50,908
+1,977
| +4% | +$25.2K | ﹤0.01% | 2508 |
|
|
2023
Q3 | $505K | Sell |
48,931
-1,225
| -2% | -$12.7K | ﹤0.01% | 2607 |
|
|
2023
Q2 | $658K | Buy |
50,156
+4,866
| +11% | +$63.8K | ﹤0.01% | 2518 |
|
|
2023
Q1 | $506K | Buy |
45,290
+1,583
| +4% | +$17.7K | ﹤0.01% | 2428 |
|
|
2022
Q4 | $368K | Buy |
43,707
+1,364
| +3% | +$11.5K | ﹤0.01% | 2598 |
|
|
2022
Q3 | $705K | Buy |
42,343
+3,093
| +8% | +$51.5K | ﹤0.01% | 2335 |
|
|
2022
Q2 | $578K | Buy |
39,250
+12,549
| +47% | +$185K | ﹤0.01% | 2419 |
|
|
2022
Q1 | $662K | Buy |
26,701
+1,617
| +6% | +$40.1K | ﹤0.01% | 2293 |
|
|
2021
Q4 | $804K | Sell |
25,084
-506
| -2% | -$16.2K | ﹤0.01% | 2298 |
|
|
2021
Q3 | $921K | Buy |
25,590
+1,247
| +5% | +$44.9K | ﹤0.01% | 2261 |
|
|
2021
Q2 | $1.07M | Buy |
24,343
+11,788
| +94% | +$520K | ﹤0.01% | 2215 |
|
|
2021
Q1 | $574K | Buy |
12,555
+918
| +8% | +$42K | ﹤0.01% | 2425 |
|
|
2020
Q4 | $803K | Buy |
+11,637
| New | +$803K | ﹤0.01% | 2240 |
|